Български (България)English (United Kingdom)
Българска Асоциация Диабет
http://www.badiabet.com/components/com_gk2_photoslide/images/thumbm/9163271.png http://www.badiabet.com/components/com_gk2_photoslide/images/thumbm/3261062.png http://www.badiabet.com/components/com_gk2_photoslide/images/thumbm/9529923.png http://www.badiabet.com/components/com_gk2_photoslide/images/thumbm/1547604.png http://www.badiabet.com/components/com_gk2_photoslide/images/thumbm/4997225.png
Print E-mail
Patients with diabetes will need to surcharge for insulin
Today it became clear that the company supplying the insulin "Novo Nordisk" cease to pay the price difference between the wholesaler and the reimbursement price set by the Council of Ministers prices. Thus, patients with diabetes will have to cost extra 8 levs packaging. So far the company has additionally insulin in the form of donation. Commercial wholesale price of insulin is 56 levs, and reimbursement - 48 lv. "How decided that they will suddenly stop cost extra difference ", asked the deputy director of the NHIF Albena Zlatareva and said that no formal letter from the company Why stop today will cost extra difference. Health insurance in the case of performing his duties and pay 100% of the reference price, she said. In an official statement of "Novo Nordisk", submitted to BGNES, says that prices of services provided by them are not elevated insulin and will not be promoted. "From December 1st, 2009 patients treated with human insulin of "Novo Nordisk", will cost extra to have recorded the difference between price and the reference value for the group, paid by NHIF. Now this difference is 96 cents per clip (4.80 levs per package). This measure is necessary to enable human insulin of "Novo Nordisk" to be imported and distributed in Bulgaria. The introduction of the surcharge is the result of the clustering of human insulin to the three manufacturers in the price of the cheapest drug in the group becomes a reference for the whole group. Patients who are unable or unwilling to Supplement for insulin, you'll have to turn to their treating endocrinologist replacement therapy and training in working with other injected device, provides the full text of the opinion of the supplier company. Asked whether it could lead to the situation a few months ago when thousands of diabetes in our country were threatened to stop supplies of health insurance paid by insulin from "Novo Nordisk " said Health Minister Bozidar Nanev already spoken to General Manager of the company and is ready to resolving the issue and not to get there. From the National Health Insurance Fund did replied that there was no change in the level of pay of insulin products by the treasury, it pays 100 percent of the reference price. The entry into force of the positive list of medicines (PLM) to the moment it has about 240 drugs belonging as wage levels, defined as 100%. In the PLM, it is clear that these drugs cost a wholesaler is higher than the reference value, which pays health insurance. Pick recall that on this occasion, multiple signals are making inquiries to the Commission in a positive list of medicines, the Ministry of Health and other institutions that a problem exists and must be found in the regulatory decision as soon as possible. The Vice-President of the Bulgarian Association of diabetes  Adrian Stoev told Darik radio that the protest be considered if necessary in future patients with diabetes using insulin of "Novo Nordisk" to cost extra. On Thursday Health Minister Bozidar Nanev will meet with representatives of "Noro Nordisk", to discuss the problem. And then both sides will seek possible solutions to the case. / BGNES /
 
Банер
Банер
Банер